Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

174.65 +4.01 (+2.35%)
Streaming Delayed Price Updated: 10:36 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
News headline image
Biotechnology And Healthcare, A Bit Of A Lull ↗
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
News headline image
Healthcare And Biotech Update With Market At 2024 Highs ↗
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD. 
Via Talk Markets
News headline image
3 Biotech ETFs Overdue for a Bounce ↗
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. 
Via InvestorPlace
Topics ETFs
News headline image
Millionaire Makers: 3 Sectors Poised for 20X Gains ↗
Dive into three explosive sectors that could yield 20X returns for the bold investor. Uncover these potential millionaire makers. 
Via InvestorPlace
News headline image
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. 
Via InvestorPlace
News headline image
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 ↗
Find out which under-the-radar biotech stocks have major catalysts on the horizon, and unlock their explosive growth potential. 
Via InvestorPlace
News headline image
Lottery Preference And Biotech Stocks: Trust The Financials, Not The Science ↗
Making a bet on biotech/pharma firms that have not yet achieved significant revenue is the equivalent of buying a lottery ticket—with the same poor risk/return relationship. 
Via Talk Markets
News headline image
Healthcare Stocks Are Looking Better But What About Biotech? ↗
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
Via Talk Markets
News headline image
Has The Solar ETF TAN Bottomed? ↗
The last swing high before the huge parabolic move in TAN in 2020 was exactly where the current price was. 
Via Talk Markets
Topics ETFs
News headline image
The Transportation Sector Has A Story To Tell ↗
With the market experiencing a dose of reality on interest rates, we still believe that current rates are not the worst news for the market, depending on where you look. 
Via Talk Markets
News headline image
Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
News headline image
AI, Biotech, Energy Sectors Expect M&A Revival For 2024 ↗
The AI market, along with energy and biotech, are ripe for M&A following the worst performance in almost a decade for deal-making in 2023. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Top Thematic ETF Ideas For 2024 ↗
With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven. 
Via Talk Markets
Topics Artificial Intelligence ETFs
News headline image
Bullish Continuation In '24? 3 Market Areas To Watch ↗
This article discusses 3 market areas that should outperform dramatically over the next 12 months... 
Via Talk Markets
News headline image
Markets: Week 1 Week 2 - What's Next Week 3? ↗
The growth space is getting crowded again, while the 
Via Talk Markets
News headline image
A Rough Start To 2024 What Might Be In Store For The Rest Of 2024? ↗
The market was weighed down by several negative factors that began before the bell even rang at Broad and Wall on the first trading day of this New Year. 
Via Talk Markets
News headline image
US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday? ↗
The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024. 
Via Benzinga
News headline image
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? ↗
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York. 
Via Benzinga
News headline image
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback ↗
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals. 
Via Benzinga
News headline image
Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday? ↗
The U.S. stock market saw modest gains in a session characterized by low trading volumes following the Christmas holiday. The S&P 500 Index gained 0.3% during midday trading in New York, eyeing its... 
Via Benzinga
News headline image
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday? ↗
The S&P 500 and Nasdaq 100 indices are on the verge of achieving an impressive eight consecutive weeks of gains following a more significant decline than expected in the Federal Reserve’s favored... 
Via Benzinga
Topics Economy Stocks
News headline image
US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday? ↗
On Thursday, Wall Street rebounded into positive territory, following a brief dip experienced on Wednesday. At midday trading New York time, all major stock indices were trading in the green as traders... 
Via Benzinga
News headline image
Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? ↗
Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs. 
Via Benzinga
News headline image
Biotech Is Coming Back, Can The Run Last? ↗
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. 
Via Talk Markets
News headline image
Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. 
Via Talk Markets
News headline image
Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
News headline image
You Don't Have to Pick a Winner in Biotech. Here's Why. ↗
If you invest over the long term, you'll increase your chances of victory. 
Via The Motley Fool
News headline image
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures ↗
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments. 
Via InvestorPlace
News headline image
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech ↗
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. 
Via Talk Markets
News headline image
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.